Teva Pharmaceuticals Reports Record Profits, Shares Rise 12%
Teva Pharmaceuticals (TEVA) shares surged 12% after reporting a 72% increase in net income to $369 million for Q1 2026. The company also saw a 25.6% rise in operating income, though it lowered its guidance for operating income, adjusted EBITDA, and diluted EPS for the year.
Tickers: $TEVA
Topics: Earnings Market Reaction Profit Growth Revenue Outlook Stock Performance